Eli Lilly Takes on Parkinson's

     I wrote a really good article on 9/20/13 at my previous blog: Lilly Fuel.  Its title is The Greatest Gamble.

In that post I explain that investing in the pharmaceutical business can not only earn oneself profit, it can save one's own life!  My Grandmother died from Parkinson's disease.  Since there is some hereditary correlation, I have a significant chance of getting it at some point.

When I wrote The Greatest Gamble, I was already aware of Eli Lilly & Co.'s Parkinson's treatment that is a Florbenazine Imaging Agent (now in Phase II testing).  However, what has me really excited is the discovery of another anti-Parkinson's candidate that I just came across a few days ago (in Phase I testing).

I have no idea if Lilly's new molecule is actually protective against Parkinson's.  And, even so, to be legally sold it would have to make it past the FDA.  But, consider for a moment what it would mean if it is a cure.  While it would be true that the scientists and businessmen at Eli Lilly & Co. (LLY) would get half of the credit for the medical product, I, as an investor, intellectual, and advocate for Parkinson's research might be responsible for the other half.

One day, I may be able to boast that I'm living a few extra years longer due to my work.  And, maybe I'll also be able to claim the title of having done half the work in curing Parkinson's disease!  That would be a life achievement to put under my belt.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)